Amarantus Bioscience Holdings Inc (AMBS)

[jacmar1965]

The U.S. Defense Department is soon expected to provide $17 million to fund a major study of brain-injury biomarkers in more than 1,000 human patients at 20 hospitals in the U.S. and overseas. The first-of-its-kind study—which is expected to start next year and take 18 months—will explore whether biomarkers can reliably assess the extent of brain injury and help doctors decide on treatment.

"I think this will revolutionize brain-injury care," says Col. Dallas Hack, a medical doctor in charge of the U.S. Army's combat casualty treatment. He says the Army's goal is to one day have a portable blood-test device that a medic could carry onto the battlefield.

From Banyon bio markers..